CINXE.COM

<!DOCTYPE html> <html class="no-js" lang="en"> <head><link rel="SHORTCUT ICON" href="/Media/30/Images/shortcut.ico" type="image/ico" /><title> The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services </title><link rel="canonical" href="https://www.pharmoutsourcing.com/Featured-Articles/358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand/" /> <meta name="description" content="The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand" /> <meta name="keywords" content="The, Evolving, Shape, of, the, ADC, Market:, The, Widening, Application, of, ADCs, and, Manufacturing, Improvements, Meeting, Demand" /> <meta property="og:title" content="The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand" /> <meta property="og:description" content="The scale of patient demand has fuelled an overarching healthcare market need to expand the drug development pipeline to generate more biologics to treat multiple diseases and innovative new biopharmaceuticals to further enhance the treatment of cancer." /> <meta property="og:url" content="https://www.pharmoutsourcing.com/Featured-Articles/358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand/" /> <meta property="og:image" content="https://media.pharmoutsourcing.com/m/30/article/358918.jpg" /><link type="text/css" rel="stylesheet" href="/rand-20241122020849/CommonStyleSheet.ashx" /><script type="text/javascript" src="/rand-20241122020849/AllSitesCommonJavaScript.ashx"> </script><meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1"> <script type="text/javascript" src="https://sadmin.brightcove.com/js/BrightcoveExperiences.js"></script> <script type="text/javascript" src="https://www.pharmoutsourcing.com/Media/30/Js/header_/po-omniture-242.js"></script> <meta name="google-site-verification" content="pqi6xVI-CmFz8ZMc5C4fcUMZ_nYpoyk0K-XtbQn-bKk" />  <script> !function(g,s,q,r,d){r=g[r]=g[r]||function(){(r.q=r.q||[]).push( arguments)};d=s.createElement(q);q=s.getElementsByTagName(q)[0]; d.src='//d1l6p2sc9645hc.cloudfront.net/tracker.js';q.parentNode. insertBefore(d,q)}(window,document,'script','_gs'); _gs('GSN-670983-Z'); </script>  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script> <script> (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: "ca-pub-8592226654827380", enable_page_level_ads: true }); </script> <script async='async' src='https://www.googletagservices.com/tag/js/gpt.js'></script> <script> var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; </script> <script async src="https://securepubads.g.doubleclick.net/tag/js/gpt.js"></script> <script> window.googletag = window.googletag || {cmd: []}; googletag.cmd.push(function() { googletag.defineSlot('/21803624868/PO_LDB_TOP', [728, 90], 'div-gpt-ad-1565115125252-0').addService(googletag.pubads()); googletag.pubads().enableSingleRequest(); googletag.enableServices(); }); </script>  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/katex.min.css" integrity="sha384-bYdxxUwYipFNohQlHt0bjN/LCpueqWz13HufFEV1SUatKs1cm4L6fFgCi1jT643X" crossorigin="anonymous"> <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/katex.min.js" integrity="sha384-Qsn9KnoKISj6dI8g7p1HBlNpVx0I8p1SvlwOldgi3IorMle61nQy4zEahWYtljaz" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/auto-render.min.js" integrity="sha384-+VBxd3r6XgURycqtZ117nYw44OOcIax56Z4dCRWbxyPt0Koah1uHoK0o4+/RRE05" crossorigin="anonymous" onload="renderMathInElement(document.body);"></script>  </head> <body itemscope itemtype="http://schema.org/WebPage">  <script language="JavaScript" type="text/javascript"></script> <script language="JavaScript" type="text/javascript"></script><noscript><img src="http://comparenetworks.112.2o7.net/b/ss/cn-pharmaceuticaloutsourcing/1/H.24.2--NS/0" height="1" width="1" border="0" alt="" /></noscript>  <form name="frmMain" method="post" action="/Featured-Articles/358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand/" id="frmMain" class="FeaturedArticle"> <div> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="/wEPDwUJNjUyMjEzODgzZBgBBR9jdGwwNiRjdGwyMyRjdGwwMSRtbnVOYXZpZ2F0aW9uDw9kBRV2aXNpYmxlXGhpZGRlblxoaWRkZW5kwA7YSAj52rnNawXT023UUOLMVb8=" /> </div> <script src="/WebResource.axd?d=dpIz1tUprODzzv20inh4BJEpgVUZm-xFDTggHx6QYA5KyoUf0eYDtpY-5v3MV7-YqZgVIWqIMVYe1KQYaMxNOa4kN6Q4zGHoJ-bIGU8rhqVTES-NGJ6gnzU9CVcRqWpDBWPUqZ4jjVrJAcrXfZnJTHObakYe8pAyZ1Gloq3Ir7xaZ64z0&t=638662746645838159" type="text/javascript"></script> <div> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="CA0B0334" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEdAAYPC4VQ6DX5OAMeUuG4cwmA+jzW533h9l5bUS6MDDcd9A0E/rbeztzgmLEwdQW2JILpJuhlIBdrGJGSNfKQqQV4+R1RckM16D1e1oSNbhxpIaVtzC5u1fbIR01+A3WZUFisKYBVk7SV7ozfQXDHJVqc6Hl2Eg==" /> </div> <div class="twoColumnFiveRowLayout"> <header class="pageHeaderOuter HeaderOuter module"> <div id="ctl06_pageHeader" class="pageHeader"> <div class="login" id="divLogin"> <div class="welcome"> Welcome Guest<a id="lnkFlag" class="countryFlag" title="Singapore"><img id="imgCountryFlag" title="Singapore" alt="Singapore" src="https://media.pharmoutsourcing.com/cm/sg.gif" /></a> </div> <a id="ctl06_ctl19_lnkLoginPopup" title="Sign In" class="loginPopup">Sign In</a> <a id="ctl06_ctl19_lnkRegisterPopup" title="Register" class="register-link-non-modal" href="/1574-LoginRegister/?ru=https%3a%2f%2fwww.pharmoutsourcing.com%2fFeatured-Articles%2f358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand%2f&urfd=2">Register</a> </div><a id="ctl06_ctl20_lnkHeader" title="Pharmaceutical Outsourcing" class="siteHeaderImage" href="/"><img id="ctl06_ctl20_imgHeader" title="Pharmaceutical Outsourcing" width="336" height="93" src="https://media.pharmoutsourcing.com/m/30/site/30.png" alt="Pharmaceutical Outsourcing" style="border-width:0px;" /></a> <div class="mobileMenu"><div id="ctl06_ctl21_staticHtml" class="staticHtmlModule module"> <div class="mobile-menu"> <span id="toggle-nav" class="toggle-nav"></span> </div></div> </div> <div class="searchControl module"> <input id="txtSearchFor" type="text" class="textbox" autocomplete="off"/> <input id="btnSearch" type="button" value="Search" class="button searchButton" /> <input type='hidden' id='hdnSearchResultsPageUrl' value='/PO-General-Search/' /> </div> <div id="ctl06_ctl23_divContainer" class="provider navContainer"> <div id="ctl06_ctl23_divHeader" class="header"> <h2> </h2> </div> <div class="subHomes categoryNavContainer"><div id="ctl06_ctl23_ctl00_staticHtml" class="staticHtmlModule module"><ul class="subHomesMenu menu"> <li class="active"><a title="Home" href="/">Home</a></li> <li><a title="API" href="/3736-API/">API</a></li> <li><a title="Manufacturing" href="/3737-Manufacturing/">Manufacturing</a></li> <li><a title="Clinical Trials" href="/3738-Clinical-Trials/">Clinical Trials</a></li> <li><a title="Analytical Testing" href="/3739-Analytical-Testing/">Analytical Testing</a></li> <li><a title="Cold Chain" href="/3740-Cold-Chain/">Cold Chain</a></li> </ul></div> </div> <nav class="navigaterMenu"> <div class="navMenu" id="ctl06_ctl23_ctl01_mnuNavigation"> <div class="menuHorizontal"> <ul class="menu"> <li class="first menuTrunk hasChild selected"><a href="/1562-ArticleList/" class="menuLink">Articles</a> <ul> <li class="first last menuLeaf"><a href="/3921-Facility-Tours/" class="menuLink">Facility Tours</a></li> </ul></li><li class="menuLeaf"><a href="/1585-News/" class="menuLink">News</a></li><li class="menuLeaf"><a href="/1625-Events/" class="menuLink">Events </a></li><li class="menuTrunk hasChild"><a href="/1587-Videos/" class="menuLink">Videos</a> <ul> <li class="first menuLeaf"><a href="/Clinical-Trials-Documentary/" class="menuLink">Clinical Trials Documentary</a></li><li class="last menuLeaf"><a href="/3878-Solid-Dosage-Future/" class="menuLink">A Solid Dosage Future Documentary</a></li> </ul></li><li class="menuLeaf"><a href="/1613-WhitePapers-ApplicationNotes/" class="menuLink">Whitepapers/App Notes</a></li><li class="menuLeaf"><a href="/1614-Archive-List/" class="menuLink">Issue Archives</a></li><li class="menuLeaf"><a href="/1624-Company-Focus/" class="menuLink">Company Focus</a></li><li class="menuLeaf"><a href="/1554-ProductDirectoryBranch/" class="menuLink">Service Directory</a></li><li data-on-click="Register" class="menuLeaf nav-menu-action nav-register"><a class="menuLink">Register</a></li><li data-on-click="SignIn" class="last menuLeaf nav-menu-action nav-log-in"><a class="menuLink">Sign In</a></li> </ul> </div> </div> </nav> </div> </div> </header> <div class="bodyContentOuter module"> <div class="bodyContent module"> <div id="ctl06_contentPaneHeader" class="contentPaneHeader"> <div class="leaderboard adContainer"><div id="ctl06_ctl02_staticHtml" class="staticHtmlModule module"> <span id=zone732017079></span> <script async src='//comparenetworks.engine.adglare.net/?732017079'></script></div> </div> <nav class="breadcrumbMap" itemprop="breadcrumb" > <ul> <li><a href="/" title="Home">Home</a></li><li><a href="/1562-ArticleList/" title="Articles">Articles</a></li><li><a href="/1581-Article-Archives/" title="Article Archives">Article Archives</a></li><li>The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand</li> </ul> </nav></div> <div class="contentPaneOuter module"> <div id="ctl06_contentPane" class="contentPane"> <div id="ctl06_ctl00_divContainer" class="container module primary article-container"> <div class="header"> <h1> The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand</h1> </div> <div id="ctl06_ctl00_contentPane" class="content"> <div id="ctl06_ctl00_ctl00_divContainer" class="container module default byline-container"> <div id="ctl06_ctl00_ctl00_contentPane" class="content"> <div id="ctl06_ctl00_ctl00_ctl00_divArticleDetail" class="articleModule module"> <div id="ctl06_ctl00_ctl00_ctl00_schemaData" class="schemaData"> </div> <div id="ctl06_ctl00_ctl00_ctl00_divArticleModule" class="articleModule module"><div name="section1224432" class="byline clearfix" id="section1224432"> <div class="ArticleDetailDatePublished"> Monday, March 4, 2019 </div><div id="embeddedCode" class="embeddedcode" ><div class="sharing"> <span class="tweets"><a href="http://twitter.com/share" class="twitter-share-button" data-count="horizontal" data-via="pharmaceuticaloutsourcing ">Tweet</a> </span><span class="facebook"> <div id="fb-root"> </div> <script src="https://connect.facebook.net/en_US/all.js#appId=166409440129074&xfbml=1" type="text/javascript"></script> <fb:like href="" send="false" layout="button_count" width="90" show_faces="true" font=""></fb:like> </span> <span class="linkedin"> <script src="https://platform.linkedin.com/in.js" type="text/javascript"></script> <script type="IN/Share" data-counter="right"></script> </span> </div></div></div></div> <div id="ctl06_ctl00_ctl00_ctl00_divPaging" class="paging"> </div> <div id="ctl06_ctl00_ctl00_ctl00_divComments"> </div> </div> <div id="ctl06_ctl00_ctl00_ctl01_divContentSharing" class="ContentSharing module"> <div class="contentShareModuleText"> <p></p> </div><span class="tweets"><script type="text/javascript" src="https://platform.twitter.com/widgets.js"> </script><a class="twitter-share-button" href="https://twitter.com/share" data-url="https://www.pharmoutsourcing.com/Featured-Articles/358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand/" data-count="horizontal" data-counturl="https://www.pharmoutsourcing.com/Featured-Articles/358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand/" data-via="Pharmaceutical Outsourcing">Tweet</a><meta name="twitter:card" content="summary" /></span><span class="facebook"><div id="fb-root"> </div><script type="text/javascript" src="//connect.facebook.net/en_US/all.js#xfbml=0"> </script><div class="facebookShare"> <div class="fb-share-button" data-href="https://www.pharmoutsourcing.com/Featured-Articles/358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand/" data-layout="button_count" data-mobile-iframe="false"> Facebook </div> </div></span><span class="linkedin"><script type="text/javascript" src="//platform.linkedin.com/in.js"> </script><script data-counter="right" type="IN/Share" data-url="https://www.pharmoutsourcing.com/Featured-Articles/358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand/"> Linkedin </script></span> <input type="hidden" name="ctl06$ctl00$ctl00$ctl01$hdnContentId" id="ctl06_ctl00_ctl00_ctl01_hdnContentId" value="358918" /> <input type="hidden" name="ctl06$ctl00$ctl00$ctl01$hdnPrivacyPolicy" id="ctl06_ctl00_ctl00_ctl01_hdnPrivacyPolicy" value="&lt;li class=&quot;privacyPolicy&quot;&gt;&lt;a href=&quot;/1594-Privacy-Policy/&quot; title=&quot;Privacy Policy&quot; target=&quot;_blank&quot;&gt;Privacy Policy&lt;/a&gt;&lt;/li&gt;" /> <input type="hidden" name="ctl06$ctl00$ctl00$ctl01$hdnUserInfo" id="ctl06_ctl00_ctl00_ctl01_hdnUserInfo" /> <input type="hidden" name="ctl06$ctl00$ctl00$ctl01$hdnContentUrl" id="ctl06_ctl00_ctl00_ctl01_hdnContentUrl" value="https://www.pharmoutsourcing.com/Featured-Articles/358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand/" /> <input type="hidden" name="ctl06$ctl00$ctl00$ctl01$hdnContentType" id="ctl06_ctl00_ctl00_ctl01_hdnContentType" value="4" /> </div></div> </div> <div id="ctl06_ctl00_ctl01_divArticleDetail" class="articleModule module"> <div id="ctl06_ctl00_ctl01_schemaData" class="schemaData"> <meta itemprop="name" content="The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand" /><meta itemprop="datePublished" content="Monday, March 4, 2019" /><meta itemprop="author" content=" Charlie Johnson" /> </div> <div id="ctl06_ctl00_ctl01_divArticleModule" class="articleModule module" itemscope="" itemprop="articleBody"><div name="section1224433" class="articleContent" id="section1224433"> <p></p><p><em>By Charlie Johnson, CEO of ADC Bio, adcbio.com</em></p> <p>The scale of patient demand has fuelled an overarching healthcare market need to expand the drug development pipeline to generate more biologics to treat multiple diseases and innovative new biopharmaceuticals to further enhance the treatment of cancer. The effectiveness of antibody drug conjugates and checkpoint inhibitors in combating cancer is having a massive impact on the ADC R&D market; additionally, new and exciting uses of antibody drug conjugates are also being actively researched. Data analysis by Beacon Targeted Therapies highlights this significant ADC market trend.</p> <p>As the number of ADCs used in drug development and actual healthcare treatment expands, so does pressure to intensify their development, driving advanced manufacturing techniques and supply chain innovation.</p> <h3>Growth in Oncology Drug Combination Treatments and of ADCs for Disease Treatments Beyond Cancer</h3> <p>The ADC biopharmaceuticals sector has seen a big trend towards R&D into new uses of ADCs – both in terms of combination drugs for treating cancer and the application of the drug class for the treatment of other diseases beyond the realm of cancer indications.</p> <p>Research has shown that antibody drug conjugates have application as anti-inflammatory agents, anti-microbials and anti virals. Analysis by Beacon Targeted Therapies shows that clinical trials for ADCs are already underway to test their effectiveness in treating  a number of non-cancer indications. There are currently nine trials that are focused on diffuse cutaneous systemic sclerosis, systemic sclerosis, Graft vs. Host Disease (GVHD), myeloproliferative neoplasm and myelodysplastic syndrome, HIV-1-infection, systemic lupus erythematosus, methicillin-sensitive staphylococcus aureus (MSSA), methicillin-resistant staphylococcus aureus (MRSA) and bacteraemia. The ADCs that are being used in this research include Brentuximab Vedotin and RG7861. The RG7861 antibody drug conjugate is an anti-Staphylococcus aureus ADC conjugated to dmDNA3.1 payload. The ADC is being studied in two phase I trials for S. aureus bacteraemia. </p> <p>Furthermore, phase I studies are also underway into rheumatoid arthritis treatment using ABBV-337 which is based on Adalimumab (anti-TNFalpha) conjugated with a glucocorticoid receptor. This treatment has a different mode of action to that of brentuximab-based depletion of T-Cells.</p> <p>In oncology, Beacon Targeted Therapies analysis shows that the total number of active clinical trials of ADC/Checkpoint Modulator combination drugs is 40. Checkpoint inhibitors most frequently used in combination with ADCs include  Nivolumab, Pembrolizumab and Atezolizumab (see Table 1.)</p> <h3>Table 1.   ADC & Checkpoint Combination Trials</h3> <table style="width: 75%; border-color: #000000; border-width: 2px; border-style: solid;" border="2" frame="border" rules="all" cellspacing="0"> <tbody> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;"><strong>ADC</strong></td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;"><strong>Checkpoint Modulators</strong></td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;"><strong>Number <br />of Trials</strong></td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Brentuximab vedotin</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;"> <p>Pembrolizumab (PD-1)<br />Nivolumab (PD-1)<br />Ipilimumab (CTLA-4)</p> </td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">13</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Trastuzumab Emtansine</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;"> <p>Pembrolizumab (PD-1)<br />Atezolizumab (PD-L1)<br />Utomilumab (4-1BB)</p> </td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">6</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Ladiratuzumab vedotin</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;"> <p>Pembrolizumab (PD-1)<br />Atezolizumab (PD-L1)</p> </td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">3</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Glembatumumab Vedotin</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;"> <p>Pembrolizumab (PD-1)<br />Nivolumab (PD-1)<br />Varlilumab (CD27)</p> </td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">3</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Anetumab Ravtansine</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;"> <p>Pembrolizumab (PD-1)<br />Nivolumab (PD-1)<br />Atezolizumab (PD-L1)<br />Ipilimumab (CTLA-4)</p> </td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">3</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Rovalpituzumab tesirine</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;"> <p>Nivolumab (PD-1)<br />Ipilimumab (CTLA-4)</p> </td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">2</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Mirvetuximab soravtansine</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Pembrolizumab (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">2</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Loncastuximab Tesirine</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Durvalumab (PD-L1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Enfortumab vedotin</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Pembrolizumab (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">SC-003</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">ABBV-181 (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">SC-004</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">ABBV-181 (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">SC-006</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">ABBV-181 (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">GSK2857916</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Pembrolizumab (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">MGC018</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">MGA012 (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">BMS-986148</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Nivolumab (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Tisotumab vedotin</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Pembrolizumab (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Trastuzumab Deruxtecan</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Nivolumab (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Polatuzumab Vedotin</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Atezolizumab (PD-L1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">BMS-986183</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Nivolumab (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> <tr> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Telisotuzumab vedotin</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">Nivolumab (PD-1)</td> <td style="border-color: #000000; border-style: solid; border-width: 1px; text-align: center;">1</td> </tr> </tbody> </table> <p><br />Of the 14 trials studying pembrolizumab in combination with different ADCs, four trials are in phase II. The disease indications include myeloma, endometrial cancer, breast cancer and melanoma. Six trials are in phase I/II and the disease indications studied include cervical cancer, ovarian cancer, breast cancer, DLBCL, Hodgkin lymphoma, , melanoma and other solid tumors. </p> <p>A total of 20 trials are studying combination of nivolumab and ADCs. Nivolumab in combination with BV is in phase III studies for Hodgkin lymphoma. Eight trials are studying ADCs in combination with nivolumab in phase 2 trials, mostly for Hodgkin lymphoma (only one trial is studying the combination for melanoma). Various studies for other solid tumors are mostly in phase I or phase I/II.  </p> <p>A total of six trials are evaluating atezolizumab in combinations with ADCs. One phase II trial is evaluating the combination in breast cancer. All other trials are still in phase I or phase I/II and evaluating the combinations in indications including breast cancer, DLBCL, follicular lymphoma, non-small cell lung cancer, urothelial and bladder cancer. </p> <p>Pre-clinical studies using monoclonal antibodies to target non-cytotoxic drugs are growing. In the immune-oncology space, for example, the use of the antiCD11a mAb is being utilised to target a phosphodiesterase 4 inhibitor to improve the therapeutic index of the highly potent anti-inflammatory drug (1) or liver X receptor agonists for an atherosclerosis indication (2).</p> <p>Chemical conjugation can be used instead of the fusion protein route to target a protein toxin or function protein. Examples of this include urease delivery, lintuzumab gelonin (L-DOS47) (3), ricin toxin A;  targeted delivery of siRNA (4) and the formation of chemical conjugated Fab fragment based bispecifics (5).</p> <p>The ever increasing diversity of ADCs reflecting a move to the targeted approach for a wider range of bioactives is important and must not be inhibited by the well-known supply chain complexity and cost of manufacturing.</p> <h3>Analysis of the Impact of ADC Manufacturing Innovation</h3> <p>Innovation is needed to shorten the development time of ADCs and to achieve cost savings in the ADC production. There is at present too complex a set of manufacturing processes carried out across multiple vendors in different geographic locations.</p> <h3>Advanced Manufacturing Process Innovation</h3> <p>There is great potential for further development and greater application of optimised process solutions by the CDMO industry to significantly enhance efficiency. A cutting edge  example is the opportunity to utilize tools developed specifically for ADC development and manufacturing such as Lock-Release. This technique streamlines bioconjugation into four simple steps. The technology locks the antibody (mAb) to a resin, performs the conjugation, washes the locked ADC free of residuals and then releases the purified ADC.</p> <p>The technology is central to a new integrated bioconjugation concept that is being verified – a technique in which one combined process achieves both mAb purification and conjugation. This integration of the Lock-Release-mediated ADC process into the platform mAb process is transformational. Lock-Release starts with antibody supernatants and facilitates both the antibody capture step and subsequent conjugation of the toxin-linker to generate the ADC.</p> <p>Consequently, the starting point for conjugation will no longer be constrained to the use of purified antibodies as with this new process, it can instead begin anywhere between first capture of the mAb from the cell culture supernatant onto an affinity Lock-Release resin and the final stage mAb process operations typically employed. Due to the fact that this involves the handling of highly potent cytotoxins, it will require the conjugation and purification processes to be carried out by integrated bioconjugation CDMOs with the necessary high containment infrastructure.  The regulatory requirements for viral inactivation, viral clearance and final polishing steps can then be met post-conjugation.</p> <p>An integrated process  saves  an estimated 8 months in preparing Phase I material from a defined ADC candidate – 24 months instead of 32.  This approach treats the antibody as a process intermediate rather than qualified drug substance. The technique eliminates repeated incoming QC analytics, mAb formulation and stability, shipping delays/risks and separate scale-up studies, reduces material wastage and involves less contingency planning. Compression of timelines by 8 months is critical in an oncology setting, and can be the difference between a life saving or life extending option for patients.</p> <p>Lock-Release affinity resins enhance the integration of the conjugation step into the mAb platform process, by providing both purification capability and compatibility with conjugation conditions.</p> <p>This innovative, advanced manufacturing technique would revolutionise the ADC production industry – seeing the industry shift from the current separated process approach to one in which the entire supply chain is considered as a continuum with only the final ADC considered as a product.</p> <p>The integrated process enables supply chain optimisation; one CDMO facility can perform operations typically provided by 2 or 3 service providers (or separate facilities of one provider).   The advantages of such an integrated process platform outweigh the effort involved in its development, validation, operational risk assessment and implementation of facility segregation.</p> <h3>Conclusion</h3> <p>The market is seeing significant growth in studies focused on the use of ADCs to treat other diseases and conditions beyond the realm of cancer - with the numbers of such drugs in active clinical trials growing monthly. Furthermore, the use of ADCs in combination with checkpoint inhibitors is a further growth area in anti-cancer treatment with a large number of such biopharmaceuticals now in clinical trials.</p> <p>The ADC drug market is set to see significant advances in manufacturing efficiency with the improvements achieved through process innovation. This will include the integration of bioconjugation with mAB purification through a highly novel downstream development process which provides the benefit of just one set of manufacturing, analytical development and release processes, reduces costs and speeds up manufacturing and development time by as much as 8 months. For drug developers who historically have been ultra-conservative in adopting changes to tried and tested manufacturing methods, the allure of significant extension of patent protection is a compelling reason to seriously consider early implementation of integrated processes.</p> <h3>References</h3> <ol> <li>Yu, Shan, Aaron D Pearson, Reyna KV Lim, David T Rodgers, Sijia Li, Holly B Parker, Meredith Weglarz, et al. “Targeted Delivery of an Anti-Inflammatory PDE4 Inhibitor to Immune Cells via an Antibody–Drug Conjugate.” Molecular Therapy 24, no. 12 (December 1, 2016): 2078–89. https://doi.org/10.1038/mt.2016.175.</li> <li>Lim, Reyna K. V., Shan Yu, Bo Cheng, Sijia Li, Nam-Jung Kim, Yu Cao, Victor Chi, et al. “Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug Conjugate.” Bioconjugate Chemistry 26, no. 11 (November 18, 2015): 2216–22. https://doi.org/10.1021/acs.bioconjchem.5b00203</li> <li>Duzkale, Hatice, Lance C. Pagliaro, Michael G. Rosenblum, Ali Varan, Baoshun Liu, James Reuben, William G. Wierda, et al. “Bone Marrow Purging Studies in Acute Myelogenous Leukemia Using the Recombinant Anti-CD33 Immunotoxin HuM195/RGel.” Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 9, no. 6 (June 2003): 364–72.</li> <li>Duzkale, Hatice, Lance C. Pagliaro, Michael G. Rosenblum, Ali Varan, Baoshun Liu, James Reuben, William G. Wierda, et al. “Bone Marrow Purging Studies in Acute Myelogenous Leukemia Using the Recombinant Anti-CD33 Immunotoxin HuM195/RGel.” Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 9, no. 6 (June 2003): 364–72.</li> <li>Kim, Chan Hyuk, Jun Y. Axup, Anna Dubrovska, Stephanie A. Kazane, Benjamin A. Hutchins, Erik D. Wold, Vaughn V. Smider, and Peter G. Schultz. “Synthesis of Bispecific Antibodies Using Genetically Encoded Unnatural Amino Acids.” Journal of the American Chemical Society 134, no. 24 (June 20, 2012): 9918–21. https://doi.org/10.1021/ja303904e.</li> </ol></div><div name="section1224434" class="featuredLink" id="section1224434"> </div></div> <div id="ctl06_ctl00_ctl01_divPaging" class="paging"> <div class="pager"><div class="pagingHolder module"><div class="pageTitle"></div><ul class="pages module"><li class="previousSection"><<</li><li class="previous"><</li><li class="next">></li><li class="nextSection">>></li></ul></div></div> </div> <div id="ctl06_ctl00_ctl01_divComments"> </div> </div> </div> </div> <div id="ctl06_ctl01_divContainer" class="container module default "> <div id="ctl06_ctl01_divHeader" class="header"> <h2> Join the Discussion</h2> </div> <div id="ctl06_ctl01_contentPane" class="content"> <div id="ctl06_ctl01_ctl00_staticHtml" class="staticHtmlModule module"> <div class="commentbox"></div> <script src="https://unpkg.com/commentbox.io/dist/commentBox.min.js"></script> <script>commentBox('5768130752151552-proj')</script></div> </div> </div> </div> </div> <div class="leftSidebarOuter module"> <div id="ctl06_leftSidebar" class="leftSidebar"> <div class="adContainer mediumRectangle one"><div id="ctl06_ctl08_staticHtml" class="staticHtmlModule module"> <span id=zone282695571></span> <script async src='//comparenetworks.engine.adglare.net/?282695571'></script></div> </div><div id="ctl06_ctl09_divContainer" class="container module default "> <div id="ctl06_ctl09_divHeader" class="header"> <h2> 2024 Contract Services Directory and Guide </h2> </div> <div id="ctl06_ctl09_contentPane" class="content"> <div id="ctl06_ctl09_ctl00_staticHtml" class="staticHtmlModule module"><ul class="articleList" style=" margin: 0; padding:0; list-style-type: none;"> <li class="articleListRow" style=" padding: 0; margin: 0 auto; width: 175px;"><div class="articleListThumbnail"> <a title="2024 Contract Services Directory and Guide " href="https://www.pharmoutsourcing.com/1614-Archive-List/609725-2024-Contract-Services-Directory-and-Guide/" target="_blank" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/609725-600x800.jpg" onerror="this.onerror=null; this.src='https://media.tabletscapsules.com/m/54/article/articledefault.png'" class="articleImage" title="2024 Contract Services Directory and Guide" width="175" height="235" style="border:1px solid black;"></a> </div><h4 class="articleListTitle" style=" margin: 10px 0;"> <a href="https://www.pharmoutsourcing.com/1614-Archive-List/609725-2024-Contract-Services-Directory-and-Guide/" target=" _blank" =""="" title="2024 Annual Buyer鈥檚 Guide " rel="bookmark">2024 Contract Services Directory and Guide </a> </h4> <a class="readMore" href="https://www.pharmoutsourcing.com/1614-Archive-List/609725-2024-Contract-Services-Directory-and-Guide/" title="2024 Contract Services Directory and Guide" rel="bookmark" style=" background: linear-gradient(#0087a0,#005e81)!important; color: #fff; padding: 5px 10px; display: block; width: 64px; height: 20px; margin: 0 auto; border-radius: 3px;">View Issue</a> </li> </ul></div> </div> </div> <div class="subscription"><div id="ctl06_ctl10_staticHtml" class="staticHtmlModule module"><div class="content"> <h2> Subscriptions</h2> <a href="https://www.b2bmediaportal.com/DynamicRegister/Register.aspx?fid=APOF" target="_blank"> <img alt="Get started here for yourcomplimentary print ordigital subscription" style="border: none; margin: -37px 0 5px 0;" src="/Media/30/Images/Subscription.jpg"> Get started here for your complimentary print or<br /> digital subscription </a> <a href="https://www.b2bmediaportal.com/DynamicRegister/Register.aspx?fid=APOF" target="_blank" class="newsletter" >Sign up Now »</a> </div></div> </div><div class="adContainer mediumRectangle three"><div id="ctl06_ctl11_staticHtml" class="staticHtmlModule module"> <span id=zone158878137></span> <script async src='//comparenetworks.engine.adglare.net/?158878137'></script></div> </div><div class="adContainer mediumRectangle two"><div id="ctl06_ctl14_staticHtml" class="staticHtmlModule module"> <span id=zone524087642></span> <script async src='//comparenetworks.engine.adglare.net/?524087642'></script></div> </div><div class="adContainer mediumRectangle four"><div id="ctl06_ctl15_staticHtml" class="staticHtmlModule module"> <span id=zone564086791></span> <script async src='//comparenetworks.engine.adglare.net/?564086791'></script></div> </div><div id="ctl06_ctl17_divContainer" class="container module default "> <div id="ctl06_ctl17_divHeader" class="header"> <h2> Connect with Us</h2> </div> <div id="ctl06_ctl17_contentPane" class="content"> <div id="ctl06_ctl17_ctl00_staticHtml" class="staticHtmlModule module"><ul class="stayConnected flex-container"> <li class="facebook"><a href="https://www.facebook.com/PharmaceuticalOutsourcing" target="_blank" rel="nofollow" title="facebook">facebook</a></li> <li class="Linkedin"><a href="https://www.linkedin.com/company/pharmaceutical-outsourcing/" target="_blank" rel="nofollow" title="Linkedin" >Linkedin</a></li> <li class="twitter"><a href="https://twitter.com/PharmOutsource" target="_blank" rel="nofollow" title="Twitter" ><img src="/Media/30/Images/svg/x-logo.svg"></a></li> <li class="youTube"><a href="http://www.youtube.com/channel/UCRjiBbP8qtiJYqa6H6_Kiiw" target="_blank" rel="nofollow" title="YouTube" >YouTube</a></li> </ul> </div> </div> </div> <div id="ctl06_ctl18_divContainer" class="container module default follow"> <div id="ctl06_ctl18_divHeader" class="header"> <h2> <a href="/PO-Newsletter-Signup/" title="Sign up for our eNewsletter!">Sign up for our eNewsletter!</a></h2> </div> <div id="ctl06_ctl18_contentPane" class="content"> <div id="ctl06_ctl18_ctl00_staticHtml" class="staticHtmlModule module"><p> Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.</p> <div class="subscribe module"> <input id="txtSubscribe" type="text" class="textbox" /> <input id="btnSubscribe" type="button" value="Subscribe" class="subscribeButton" /> </div></div> </div> </div> </div> </div> </div> </div> <footer class="footerOuter module"> <div id="ctl06_footer" class="footer"> <div id="ctl06_ctl04_staticHtml" class="staticHtmlModule module"><style> .wallpaper-ad { position: absolute; width: 1445px; height: 590px; max-width: fit-content; top: 185px; border: none; inset: 185px 0 0; z-index: 0; margin-left: auto; margin-right: auto; } .twoColumnLayout .leftSidebarOuter .leftSidebar { display:block !important; } </style> <script> // Wallpaper Ad (function () { var Collider = { makeSticky: function (margin) { $('.wallpaper-ad').css({ 'position': 'absolute', 'margin-top': margin - 260 + 'px' }); }, makeFloaty: function (margin) { $('.wallpaper-ad').css({ 'position': 'fixed', 'margin-top': margin - 50 + 'px' }); }, initScroll: function () { if ($(window).width() > 760) { // Desktop only var lastScrollPos = 0; $(window).scroll(function () { var thisScrollPos = $(this).scrollTop(); if (thisScrollPos > lastScrollPos) { Collider.checkDownScroll(); } else { Collider.checkUpScroll(); } lastScrollPos = thisScrollPos; }); } }, checkDownScroll: function () { var collider = $('.wallpaper-ad').height() + $('.wallpaper-ad').offset().top + 30, fense = $('footer').offset().top; if (collider >= fense) { this.makeSticky($('.footer').offset().top - $('.wallpaper-ad').height()); } }, checkUpScroll: function () { var fense = $('footer').offset().top - $('.wallpaper-ad').height() - 148; if ($(window).scrollTop() <= fense) { this.makeFloaty(118); } } }; Collider.initScroll(); })(); </script> </div> <div class="baseboard adContainer"><div id="ctl06_ctl05_staticHtml" class="staticHtmlModule module"> <span id=zone467266134></span> <script async src='//comparenetworks.engine.adglare.net/?467266134'></script> </div> </div><div id="ctl06_ctl06_divFooter"><div class="footer-html"> <div class="footerColumn first"> <img src="https://www.pharmoutsourcing.com/Media/30/Images/FooterLogo.gif" style="max-width: 235px;" alt="Pharmaceutical Outsourcing"> <p> Pharmaceutical Outsourcing is the leading review of business and technology for the pharmaceutical industry throughout North America.<br> <br> <img src="https://media.pharmoutsourcing.com/m/30/site/po_25th_anniversary.png" style="max-width: 235px;" alt="Pharmaceutical Outsourcing 25th anniversary"><br> A Publication of <a href="http://corp.comparenetworks.com" title="A Site by CompareNetworks" rel="nofollow" style="display: block;" target="_blank"> <img style="border: none; width: 180px;" src="/Media/28/Images/cn_retina.png" alt="A Site by CompareNetworks" /></a> <a title="See our other sites 禄" href="/2212-CompareNetworks/"><b>See our other sites 禄</b></a> </p> <h4> Connect with Us </h4> <div class="FL-Article"> <div class="ContentSharing"> <a target="_blank" href="https://twitter.com/PharmOutsource"> <span class="tweets"> <img alt="X" src="https://www.pharmoutsourcing.com/Media/30/Images/svg/x-logo-white.svg" width="15px" /> </span> </a> <a target="_blank" href="https://www.facebook.com/PharmaceuticalOutsourcing"> <span class="facebook"> <img alt="facebook" src="https://www.pharmoutsourcing.com/Media/30/Images/svg/facebook-white.svg" width="25px" height="25px" /> </span> </a> <a target="_blank" href="https://www.linkedin.com/company/pharmaceutical-outsourcing/"> <span class="linkedin"> <img src="https://www.pharmoutsourcing.com/Media/30/Images/svg/linkedin-white.svg" alt="linkedin" width="25px" height="25px" /> </span></a> <a title="YouTube" target="_blank" href="https://www.youtube.com/channel/UCRjiBbP8qtiJYqa6H6_Kiiw" rel="nofollow"> <span class="youtube"><img alt="YouTube" src="https://www.pharmoutsourcing.com/Media/30/Images/svg/youtube-white.svg" width="30px" height="30px" style="margin-top: -7px;" /> </span> </div> </a> </div> <p class="copyright"> Copyright © 2024 <a href="http://corp.comparenetworks.com" title="CompareNetworks Corporate Site" rel="nofollow" target="_blank">CompareNetworks, Inc</a>. All rights reserved. </p> </div> <div class="footerColumn"> <h4> About PO </h4> <ul class="menu" style="margin-bottom: 35px;"> <li><a href="/1610-About-Us/" title="About Pharmaceutical Outsourcing">About Us</a> </li> <li><a href="/1592-Contact-Us/" title="Contact Pharmaceutical Outsourcing" rel="nofollow">Contact Us</a> </li> <li><a href="/1604-Press-Room/" title="Press Room" rel="nofollow">Press Room</a> </li> <li class="first"><a href="/1594-Privacy-Policy/" title="Pharmaceutical Outsourcing Privacy Policy" rel="nofollow">Privacy Policy</a> </li> <li><a href="/1595-Disclaimer-Terms-of-Use/" title="Pharmaceutical Outsourcing Disclaimer" rel="nofollow">Disclaimer</a> </li> </ul> <h4> Advertise with Us </h4> <ul class="menu"> <li><a href="https://comparenetworks.wufoo.com/forms/request-a-media-kit-qnyb16c1gpdf5j" target=_blank title="Request Media Kit" rel="nofollow">Media Kit Request</a> </li> </ul> </div> <div class="footerColumn"> <h4> Resources </h4> <ul class="menu"> <li><a title="Issue Archive" href="/1614-Archive-List/">Issue Archive </a></li> <li><a title="Service Directory" href="https://www.pharmoutsourcing.com/1554-ProductDirectoryBranch/">Service Directory </a></li> <li><a title="Issue Archive" href="https://www.pharmoutsourcing.com/3878-Solid-Dosage-Future/">Solid Dosage Documentary</a></li> <li><a title="API" href="/3736-API/">API</a> </li> <li><a title="Manufacturing" href="/3737-Manufacturing/">Manufacturing</a> </li> <li><a title="Clinical Trials" href="/3738-Clinical-Trials/">Clinical Trials</a></li> <li><a title="Analytical Testing" href="/3739-Analytical-Testing/">Analytical Testing</a> </li> <li><a title="Cold Chain" href="/3740-Cold-Chain/">Cold Chain</a></li> </ul> </div> <div class="footerColumn"> <h4> Subscription </h4> <ul class="menu"> <ul class="menu" style="margin-bottom: 35px;"> <li><a title="Subscribe eNewsletters" href="/PO-Newsletter-Signup/">Subscribe eNewsletters</a> </li> <li><a title="Subscribe Magazine" target="_blank" href="http://www.b2bmediaportal.com/dynamicregister/register.aspx?fid=APOF&status=NEW">Subscribe Magazine</a> </li> <li><a target="_blank" href="http://www.b2bmediaportal.com/dynamicregister/register.aspx?fid=APOF">Manage Your Print Subscription</a></li> </ul> </div> </div></div><div id="ctl06_ctl07_staticHtml" class="staticHtmlModule module"><style> .jqmWindow.jqmID1 .formList .description{ white-space: nowrap; text-align: left; } .jqmWindow.jqmID1 .formHolder ul li { display: block; } .jqmWindow.jqmID1 .formHolder { padding: 0; margin: 30px 0 0 0 !important; } .jqmWindow.jqmID1 .leftLabel li div.inputElements{ width: auto; } </style></div> </div> </footer> </div> <div id="modalPopup" class="jqmWindow"> </div> <script type="text/javascript"> //<![CDATA[ MakeHoverMenu('ctl06_ctl23_ctl01_mnuNavigation');//]]> </script> </form> <script src="https://ak.sail-horizon.com/spm/spm.v1.min.js"></script> <script type="text/javascript">try{ Sailthru.init({ customerId: "6b0e3918dfddbec7995c67ba4e3ffdf1" ,isCustom: true, autoTrackPageview: false, useStoredTags: false }); } catch(err){ console.warn('sailthru initialization failed'); } </script> <script type="text/javascript">VP.BaseUrl = '/';VP.AjaxWebServiceUrl = '/WebServices/AjaxService.asmx';VP.SiteId = 30;VP.PageId = 1582;VP.PredefinedPageId = 0;</script><script type="text/javascript"> $("#divLogin").append($("<a class='subscribeHeader' href='https://www.b2bmediaportal.com/DynamicRegister/Register.aspx?fid=APOF' target='_blank'>Subscribe</a>"));</script> <script> (function (d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "//connect.facebook.net/en_US/all.js#xfbml=1"; fjs.parentNode.insertBefore(js, fjs); } (document, 'script', 'facebook-jssdk')); </script><script type="text/javascript"> $(document).ready(function() {VP.Login.CurrentPageUrl = 'https://www.pharmoutsourcing.com/Featured-Articles/358918-The-Evolving-Shape-of-the-ADC-Market-The-Widening-Application-of-ADCs-and-Manufacturing-Improvements-Meeting-Demand/'; VP.Login.SiteUrl = 'https://www.pharmoutsourcing.com//';VP.Login.PasswordResetPageUrl = 'https://www.pharmoutsourcing.com/1571-PasswordReset/';VP.Login.CountryId = 187;VP.Login.IsLogged = 'false';VP.Login.UserProfilePage = '/1568-UserProfile/';VP.Login.UserProfilePageFromCountryFlag = '/1568-UserProfile/?upti=profile';VP.Login.DefaultAdminContactEmail = 'helpdesk@comparenetworks.com';$(document).ready(function() {$(".articleModule").clickThroughTrack({});});window.truncationLength =30;});</script> <script type="text/javascript" src="/rand-20241122020849/AllSitesCommonFooterJavaScript.ashx"> </script> <script type="text/javascript" src="/rand-20241122020849/CommonJavaScript.ashx"> </script> <script type="text/javascript" src="/rand-20241122020849/keys-i-k-j-c-be/ControlJavaScript.ashx"> </script> </body> </html>